COVID-19 Phase II/III Vaccine Study (COV002)

 Vaccine Certification for International Travel - Information for COV-001/COV-002 Participants

 Booster Information for Participants

The MHRA has concluded its review of very rare and unusual blood clots in adults, and did not recommend any age restriction on the use of the vaccine. (MHRA Statement)

The Joint Committee on Vaccination and Immunisation, who provide scientific advice to the Department of Health, has suggested that on a precautionary basis, adults under 30 who are still unvaccinated should be offered an alternative Covid-19 vaccine, if available. (JCVI Statement)

This trial is being conducted across multiple locations in the UK.

Please use the links below to access information about how to participate at your local study site.

Thames Valley Area


Participate at the Oxford Vaccine Centre 


London and the surrounding areas


Participate at one of the London study sites


Hull and East Riding Area


Participate at Hull University Teaching Hospitals


Edinburgh and Lothian Area


Participate at NHS Lothian

North East of England


Participate at Newcastle Upon Tyne Hospitals


Hertfordshire Area


Participate at Northwick Park



Nottinghamshire, Derbyshire, Lincolnshire and Leicestershire Area

Participate at Nottingham University Hospitals


Cambridgeshire Area


Participate at Cambridge University Hospitals